相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis
Kathrin Weber et al.
COMMUNICATIONS BIOLOGY (2018)
Necroptosis Execution Is Mediated by Plasma Membrane Nanopores Independent of Calcium
Uris Ros et al.
CELL REPORTS (2017)
Tumor vaccines with dsRNA adjuvant ARNAX induces antigen-specific tumor shrinkage without cytokinemia
Tsukasa Seya et al.
ONCOIMMUNOLOGY (2016)
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
Gabriela Brumatti et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
Scott McComb et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by Taxol
V. G. Minero et al.
CELL CYCLE (2015)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL
Robbie Carson et al.
CLINICAL CANCER RESEARCH (2015)
PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo
Ryo Takemura et al.
CANCER IMMUNOLOGY RESEARCH (2015)
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Pratyusha Mandal et al.
MOLECULAR CELL (2014)
Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
Huayi Wang et al.
MOLECULAR CELL (2014)
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Tom Vanden Berghe et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
Kai Naumann et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
William J. Kaiser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor
Florent Toscano et al.
JOURNAL OF IMMUNOLOGY (2013)
Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral sqaumous cell carcinoma
Jong-Hwan Park et al.
ACTA ODONTOLOGICA SCANDINAVICA (2012)
Defective NF-κB Signaling in Metastatic Head and Neck Cancer Cells Leads to Enhanced Apoptosis by Double-Stranded RNA
Naoki Umemura et al.
CANCER RESEARCH (2012)
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8
Y. Estornes et al.
CELL DEATH AND DIFFERENTIATION (2012)
Toll-like receptor 3-mediated tumor invasion in head and neck cancer
Hui-Ching Chuang et al.
ORAL ONCOLOGY (2012)
Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling
Alejandra Garcia-Cattaneo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic
Benjamin Verillaud et al.
INFECTIOUS AGENTS AND CANCER (2012)
FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity
Cristina Pop et al.
BIOCHEMICAL JOURNAL (2011)
TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
Bruno Salaun et al.
CANCER RESEARCH (2011)
cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
Maria Feoktistova et al.
MOLECULAR CELL (2011)
The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
Tencho Tenev et al.
MOLECULAR CELL (2011)
Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway
Sudan He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
Luc Friboulet et al.
BMC CANCER (2010)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents
T. Sanchez-Perez et al.
CELL DEATH AND DIFFERENTIATION (2010)
Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells
A. Weber et al.
CELL DEATH AND DIFFERENTIATION (2010)
Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
Sarah R. Walker et al.
MOLECULAR PHARMACOLOGY (2010)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
Innate immunity to virus infection
Osamu Takeuchi et al.
IMMUNOLOGICAL REVIEWS (2009)
Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas
Camilla Rydberg et al.
IMMUNOLOGY (2009)
TLR3 Ligand Induces NF-κB Activation and Various Fates of Multiple Myeloma Cells Depending on IFN-α Production
David Chiron et al.
JOURNAL OF IMMUNOLOGY (2009)
Reconstitution of the Death-inducing Signaling Comp ex Reveals a Substrate Switch that Determines CD95-Mediated Death or Survival
Michelle A. Hughes et al.
MOLECULAR CELL (2009)
Death receptor signal transducers: nodes of coordination in immune signaling networks
Nicholas S. Wilson et al.
NATURE IMMUNOLOGY (2009)
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Duan-Wu Zhang et al.
SCIENCE (2009)
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism
Alessio Paone et al.
CARCINOGENESIS (2008)
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation
Eugene Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Identification of RIP1 kinase as a specific cellular target of necrostatins
Alexei Degterev et al.
NATURE CHEMICAL BIOLOGY (2008)
Recurrent Overexpression of c-IAP2 in EBV-Associated Nasopharyngeal Carcinomas: Critical Role in Resistance to Toll-like Receptor 3-Mediated Apoptosis
Luc Friboulet et al.
NEOPLASIA (2008)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma
Teppei Morikawa et al.
CLINICAL CANCER RESEARCH (2007)
Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
Bruno Salaun et al.
CLINICAL CANCER RESEARCH (2007)
Ubiquitination of RIP1 regulates an NF-κB independent cell-death switch in TNF signaling
Marie Anne O'Donnell et al.
CURRENT BIOLOGY (2007)
Cellular FLICE-like inhibitory protein (c-FLIP): A novel target for Taxol-induced apoptosis
Travis W. Day et al.
BIOCHEMICAL PHARMACOLOGY (2006)
TLR3 can directly trigger apoptosis in human cancer cells
Bruno Salaun et al.
JOURNAL OF IMMUNOLOGY (2006)
Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP
L Galligan et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Activation of caspases-8 and-10 by FLIPL
KM Boatright et al.
BIOCHEMICAL JOURNAL (2004)
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
RD Ramirez et al.
CANCER RESEARCH (2004)
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation
S Hopkins-Donaldson et al.
CELL DEATH AND DIFFERENTIATION (2003)
Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression
MM Kelly et al.
CANCER BIOLOGY & THERAPY (2002)